Immune activation and the pathogenesis of HIV disease: implications for therapy
- PMID: 20218239
Immune activation and the pathogenesis of HIV disease: implications for therapy
Similar articles
-
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature. 1997 May 8;387(6629):183-8. doi: 10.1038/387183a0. Nature. 1997. PMID: 9144289
-
T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.J Infect Dis. 2005 Mar 1;191(5):694-701. doi: 10.1086/427516. Epub 2005 Jan 31. J Infect Dis. 2005. PMID: 15688282
-
[New biological monitoring of HIV infection].Rev Prat. 1998 Mar 1;48(5):472-7. Rev Prat. 1998. PMID: 9781107 French. No abstract available.
-
Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.Eur Cytokine Netw. 2004 Oct-Dec;15(4):279-89. Eur Cytokine Netw. 2004. PMID: 15627636 Review.
-
Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness.SADJ. 2008 Nov;63(10):552, 554, 556-7. SADJ. 2008. PMID: 19322966 Review.
Cited by
-
HIV as a Cause of Immune Activation and Immunosenescence.Mediators Inflamm. 2017;2017:6825493. doi: 10.1155/2017/6825493. Epub 2017 Oct 25. Mediators Inflamm. 2017. PMID: 29209103 Free PMC article. Review.
-
Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy.Future Virol. 2012 Aug;7(8):819-832. doi: 10.2217/fvl.12.69. Future Virol. 2012. PMID: 23125871 Free PMC article.
-
The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients.Ethiop J Health Sci. 2017 Nov;27(6):613-620. doi: 10.4314/ejhs.v27i6.6. Ethiop J Health Sci. 2017. PMID: 29487470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical